Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of RTA 402 5 mg Tablets vs 5 mg Capsules Under Fed Conditions
jRCT2051230060Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bardoxolone methyl in diabetic glomerulosclerosis (2 arms), sponsored by Kyowa Kirin. Primary endpoints: Cmax and AUC0-t. Started Jun 2021; status: completed.
02
Drugs
bardoxolone methyl
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on jRCT2051230060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051230060.